nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A β-Blocker Trial in Dialysis Patients: Is It Feasible and Worthwhile?
|
Miskulin, Dana |
|
2016 |
67 |
6 |
p. 822-825 4 p. |
artikel |
2 |
A Custom Targeted Next-Generation Sequencing Gene Panel for the Diagnosis of Genetic Nephropathies
|
Larsen, Christopher P. |
|
2016 |
67 |
6 |
p. 992-993 2 p. |
artikel |
3 |
Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data
|
Grams, Morgan E. |
|
2016 |
67 |
6 |
p. 872-880 9 p. |
artikel |
4 |
Acute Kidney Injury in Low-Resource Settings: Barriers to Diagnosis, Awareness, and Treatment and Strategies to Overcome These Barriers
|
Lunyera, Joseph |
|
2016 |
67 |
6 |
p. 834-840 7 p. |
artikel |
5 |
Advances in Urine Microscopy
|
Becker, Gavin J. |
|
2016 |
67 |
6 |
p. 954-964 11 p. |
artikel |
6 |
AJKD Atlas of Renal Pathology: Acute Interstitial Nephritis
|
Fogo, Agnes B. |
|
2016 |
67 |
6 |
p. e35-e36 nvt p. |
artikel |
7 |
AJKD Atlas of Renal Pathology: Toxic Acute Tubular Injury
|
Fogo, Agnes B. |
|
2016 |
67 |
6 |
p. e31-e32 nvt p. |
artikel |
8 |
AJKD Atlas of Renal Pathology: Tubular Atrophy
|
Lusco, Mark A. |
|
2016 |
67 |
6 |
p. e33-e34 nvt p. |
artikel |
9 |
A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
|
Brigandi, Richard A. |
|
2016 |
67 |
6 |
p. 861-871 11 p. |
artikel |
10 |
C4 Glomerulopathy: A Disease Entity Associated With C4d Deposition
|
Sethi, Sanjeev |
|
2016 |
67 |
6 |
p. 949-953 5 p. |
artikel |
11 |
CKD and Health-Related Quality of Life: The Korea National Health and Nutrition Examination Survey
|
Park, Ji In |
|
2016 |
67 |
6 |
p. 851-860 10 p. |
artikel |
12 |
CKD for Primary Care Practitioners: Can We Cut to the Chase Without Too Many Shortcuts?
|
Thavarajah, Sumeska |
|
2016 |
67 |
6 |
p. 826-829 4 p. |
artikel |
13 |
Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis
|
O’Lone, Emma |
|
2016 |
67 |
6 |
p. 925-935 11 p. |
artikel |
14 |
Contents
|
|
|
2016 |
67 |
6 |
p. A5-A9 nvt p. |
artikel |
15 |
Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD
|
Markossian, Talar |
|
2016 |
67 |
6 |
p. 965-977 13 p. |
artikel |
16 |
Editorial Board
|
|
|
2016 |
67 |
6 |
p. A3-A4 nvt p. |
artikel |
17 |
Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis
|
Su, Xiaole |
|
2016 |
67 |
6 |
p. 881-892 12 p. |
artikel |
18 |
Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial
|
de Vries, Laura V. |
|
2016 |
67 |
6 |
p. 936-944 9 p. |
artikel |
19 |
Erratum Regarding “World Kidney Day 2016: Averting the Legacy of Kidney Disease—Focus on Childhood” (Am J Kidney Dis. 2016;67[3]:349-354)
|
|
|
2016 |
67 |
6 |
p. 997- 1 p. |
artikel |
20 |
Febuxostat for Asymptomatic Hyperuricemia in CKD
|
Mome, Ruth |
|
2016 |
67 |
6 |
p. 989- 1 p. |
artikel |
21 |
Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia
|
Filiopoulos, Vassilis |
|
2016 |
67 |
6 |
p. 989-990 2 p. |
artikel |
22 |
Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD
|
Mukundan, Srinivasan |
|
2016 |
67 |
6 |
p. 984-988 5 p. |
artikel |
23 |
Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS)
|
Bansal, Nisha |
|
2016 |
67 |
6 |
p. 994-996 3 p. |
artikel |
24 |
Hemophagocytic Syndrome With Histiocytic Glomerulopathy and Intraglomerular Hemophagocytosis
|
Santoriello, Dominick |
|
2016 |
67 |
6 |
p. 978-983 6 p. |
artikel |
25 |
Improving Our Understanding of Quality of Life in CKD
|
Wyld, Melanie L.R. |
|
2016 |
67 |
6 |
p. 820-821 2 p. |
artikel |
26 |
In Reply to ‘Febuxostat for Asymptomatic Hyperuricemia in CKD' and ‘Febuxostat Renoprotection in CKD Patients With Asymptomatic Hyperuricemia’
|
Sircar, Dipankar |
|
2016 |
67 |
6 |
p. 990-991 2 p. |
artikel |
27 |
In Reply to ‘Iohexol Versus Iothalamate for GFR Measurement’
|
Larson, Timothy S. |
|
2016 |
67 |
6 |
p. 991-992 2 p. |
artikel |
28 |
Iohexol Versus Iothalamate for GFR Measurement
|
Sterner, Gunnar |
|
2016 |
67 |
6 |
p. 991- 1 p. |
artikel |
29 |
July Highlights
|
|
|
2016 |
67 |
6 |
p. A10-A12 nvt p. |
artikel |
30 |
Long-term Follow-up of a Reused Kidney Allograft
|
Yıldız, Serkan |
|
2016 |
67 |
6 |
p. 992- 1 p. |
artikel |
31 |
Masthead
|
|
|
2016 |
67 |
6 |
p. A2- 1 p. |
artikel |
32 |
Noncompaction of the Ventricular Myocardium and Polycystic Kidney Disease: A Case Report
|
Fukino, Keiko |
|
2016 |
67 |
6 |
p. 945-948 4 p. |
artikel |
33 |
Prediabetes and Risk of Glomerular Hyperfiltration and Albuminuria in the General Nondiabetic Population: A Prospective Cohort Study
|
Melsom, Toralf |
|
2016 |
67 |
6 |
p. 841-850 10 p. |
artikel |
34 |
Prediabetes as a Precursor to Diabetic Kidney Disease
|
De Nicola, Luca |
|
2016 |
67 |
6 |
p. 817-819 3 p. |
artikel |
35 |
Quiz Page JUNE 2016
|
Gandhi, Amibahen |
|
2016 |
67 |
6 |
p. A15-A17 nvt p. |
artikel |
36 |
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
|
Provenzano, Robert |
|
2016 |
67 |
6 |
p. 912-924 13 p. |
artikel |
37 |
The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial
|
Roberts, Matthew A. |
|
2016 |
67 |
6 |
p. 902-911 10 p. |
artikel |
38 |
This Month in AJKD
|
|
|
2016 |
67 |
6 |
p. A13-A14 nvt p. |
artikel |
39 |
Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT)
|
Verbalis, Joseph G. |
|
2016 |
67 |
6 |
p. 893-901 9 p. |
artikel |
40 |
Variability May Be the “Law of Life,” but Blood Pressure Variability May Forebode a Shorter Life
|
Assimon, Magdalene M. |
|
2016 |
67 |
6 |
p. 830-833 4 p. |
artikel |